Expression of vascular endothelial growth factor related to 72- kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors

Cancer

Volumn 85, Issue 10, 1999, Pages 2219-2225

  Garzetti, G Gioele ^a,b   Ciavattini, Andrea ^a   Lucarini, Guendalina ^a   Pugnaloni, Armanda ^a   De Nictolis, Michele ^a   Amati, Silvana ^a   Romanini, Carlo ^a   Biagini, Graziella ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Ospedale Pediatrico G Salesi   (Italy)

Author keywords

Collagenase; Cystoadenocarcinoma; Cystoadenoma; Disease free survival; Gelatinase A; Metalloproteinase; Ovary; Prognosis; Proteases; Recurrence; Vascular endothelial growth factor

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; MATRIX METALLOPROTEINASE; METALLOPROTEINASE 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CYSTADENOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; CYSTADENOCARCINOMA, SEROUS; ENDOTHELIAL GROWTH FACTORS; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0345711456     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990515)85:10<2219::AID-CNCR17>3.0.CO;2-S     Document Type: Article

References (36)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. Liotta L, Kleinerman J, Saidel G. Quantitative relationship of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974;34: 997-1004.
3. Weidner N, Semple JP, Welch WR, Folkman J. Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
4. Karlan BY, Platt LD. Ovarian cancer screening: the role of ultrasound in early detection. Cancer 1995;76:2011-5.
5. Brustmann H, Riss P, Naudé S. The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary: a quantitative histologic study. Gynecol Oncol 1997;67:20-7.
6. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986;46: 5629-32.
7. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-8.
8. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-20.
9. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-62.
10. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, et al. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian cancer. J Natl Cancer Inst 1995;87:506-16.
11. Chambers AF, Matrisian LM. Changing view of the role of matrix metalloproteinases in metastases. J Natl Cancer Inst 1997;89:1260-70.
12. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153:557-62.
13. Martinez-Hernandez A, Amenta PS. The basement membrane in pathology. Lab Invest 1983;48:656-77.
14. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Griogioni WG. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 1991;4:239-46.
15. Levy A, Cioce V, Sobel ME, Garbisa S, Griogioni WF, Liotta LA. Increased expression of the 72 KDa type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991;51: 439-44.
16. Monteagudo C, Merino MJ, San Juan J, Liotta LA, Stetler-Stevenson WG. Immunohistochemical distribution of the type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol 1990;136:585-92.
17. Campo E, Tavassoli FA, Charonis AS, Stetler-Stevenson WG, Liotta LA, Merino MJ. Evaluation of basement membrane components and the 72 KDa type IV collagenase in serous tumors of the ovary. Am J Pathol 1992;6:500-7.
18. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, Romanini C, Biagini G. Increased serum 72 kDa metalloproteinase in serous ovarian tumors: comparison with CA125. Anticancer Res 1996;16:2123-8.
19. De Nictolis M, Garbisa S, Lucarini G, Goteri G, Masiero L, Ciavattini A, et al. 72-kiloDalton type IV collagenase, type IV collagen, and Ki67 antigen in serous tumors of the ovary: a clinicopathologic, immunohistochemical, and serological study. Int J Gynecol Pathol 1996;15:102-9.
20. Pettersson F. Annual report on the results of treatment in gynecological cancer. FIGO (Stockholm) 1988;20:111-2.
21. Hayashi T, Fleming MV, Stetler-Stevenson WG, Liotta LA, Moss J, Ferrans VJ, et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol 1997;28:1071-8.
22. Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, et al. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest 1996;74:1105-15.
23. Leake JF, Currie JL, Rosenshein NB, Woodruff JD. Long-term follow-up of serous ovarian tumor of low malignant potential. Gynecol Oncol 1992;47:150-8.
24. Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 1997;80:98-106.
25. Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, Sakahara H, et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 1997;76:1221-7.
26. Nakanishi Y, Komada J, Yoshinouchi M, Tokumo K, Kamimura S, Okuda H. The expression of vascular endothelial growth factor and transforming growth factor-beta associated with angiogenesis in epithelial ovarian cancer. Int J Gynecol Pathol 1997;16:256-62.
27. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastases and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
28. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cell transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8.
29. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinse-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 1992;84:1017-22.
30. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, De Nictolis M, Romanini C, et al. Recurrence patterns in locally advanced cervical carcinoma: role of nodal status and 72 kDa metalloproteinase index. Gynecol Oncol 1996;61:83-9.
31. Meyer JS, He W. High proliferative rates demonstrated by bromodeoxyuridine labeling in breast carcinoma with p53 overexpression. J Surg Oncol 1994;56:146-52.
32. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 1993;99:18-23.
33. Takemura M, Azuma C, Kimura T, Kanai T, Saji F, Tanizawa O. Type-IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues. Int J Gynecol Obstet 1994; 46:303-9.
34. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992;189:824-31.
35. Lamoreaux WJ, Fitzgerald ME, Reiner A, Hasty KA, Charles ST. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 1998;55:29-42.
36. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998;75:780-6.